These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16959772)

  • 1. Dyrk1A phosphorylates alpha-synuclein and enhances intracellular inclusion formation.
    Kim EJ; Sung JY; Lee HJ; Rhim H; Hasegawa M; Iwatsubo T; Min do S; Kim J; Paik SR; Chung KC
    J Biol Chem; 2006 Nov; 281(44):33250-7. PubMed ID: 16959772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-specificity tyrosine phosphorylation-regulated kinase 1A promotes the inclusion of amyloid precursor protein exon 7.
    Chu D; Lei L; Gu S; Liu F; Wu F
    Biochem Pharmacol; 2024 Jun; 224():116233. PubMed ID: 38663682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DYRK1A autophosphorylation on serine residue 520 modulates its kinase activity via 14-3-3 binding.
    Alvarez M; Altafaj X; Aranda S; de la Luna S
    Mol Biol Cell; 2007 Apr; 18(4):1167-78. PubMed ID: 17229891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B.
    Yousefelahiyeh M; Xu J; Alvarado E; Yu Y; Salven D; Nissen RM
    PLoS One; 2018; 13(11):e0207779. PubMed ID: 30496304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DYRK1A: a down syndrome-related dual protein kinase with a versatile role in tumorigenesis.
    Laham AJ; Saber-Ayad M; El-Awady R
    Cell Mol Life Sci; 2021 Jan; 78(2):603-619. PubMed ID: 32870330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Truncated Dyrk1A aggravates neuronal apoptosis by inhibiting ASF-mediated Bcl-x exon 2b inclusion.
    Zhang S; Zhong J; Xu L; Wu Y; Xu J; Shi J; Gu Z; Li X; Jin N
    CNS Neurosci Ther; 2024 Apr; 30(4):e14493. PubMed ID: 37864462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Dual-Specificity Kinase DYRK1A Modulates the Levels of Cyclin L2 To Control HIV Replication in Macrophages.
    Kisaka JK; Ratner L; Kyei GB
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome.
    Shi J; Zhang T; Zhou C; Chohan MO; Gu X; Wegiel J; Zhou J; Hwang YW; Iqbal K; Grundke-Iqbal I; Gong CX; Liu F
    J Biol Chem; 2008 Oct; 283(42):28660-9. PubMed ID: 18658135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficits in neuronal architecture but not over-inhibition are main determinants of reduced neuronal network activity in a mouse model of overexpression of Dyrk1A.
    Manubens-Gil L; Pons-Espinal M; Gener T; Ballesteros-Yañez I; de Lagrán MM; Dierssen M
    Cereb Cortex; 2024 Jan; 34(1):. PubMed ID: 37997361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of brain development by the Minibrain/Rala signaling network.
    Brown M; Sciascia E; Ning K; Adam W; Veraksa A
    bioRxiv; 2024 May; ():. PubMed ID: 38766038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective DYRK1A Inhibitor for the Treatment of Neurodegenerative Diseases: Alzheimer, Parkinson, Huntington, and Down Syndrome.
    Kargbo RB
    ACS Med Chem Lett; 2020 Oct; 11(10):1795-1796. PubMed ID: 33062155
    [No Abstract]   [Full Text] [Related]  

  • 12. The dual role of c-src in cell-to-cell transmission of α-synuclein.
    Choi YR; Kim JB; Kang SJ; Noh HR; Jou I; Joe EH; Park SM
    EMBO Rep; 2020 Jul; 21(7):e50843. PubMed ID: 32618125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome.
    García-Cerro S; Martínez P; Vidal V; Corrales A; Flórez J; Vidal R; Rueda N; Arbonés ML; Martínez-Cué C
    PLoS One; 2014; 9(9):e106572. PubMed ID: 25188425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson's disease.
    Barallobre MJ; Perier C; Bové J; Laguna A; Delabar JM; Vila M; Arbonés ML
    Cell Death Dis; 2014 Jun; 5(6):e1289. PubMed ID: 24922073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice.
    Mazur-Kolecka B; Golabek A; Kida E; Rabe A; Hwang YW; Adayev T; Wegiel J; Flory M; Kaczmarski W; Marchi E; Frackowiak J
    J Neurosci Res; 2012 May; 90(5):999-1010. PubMed ID: 22252917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation.
    Jung MS; Park JH; Ryu YS; Choi SH; Yoon SH; Kwen MY; Oh JY; Song WJ; Chung SH
    J Biol Chem; 2011 Nov; 286(46):40401-12. PubMed ID: 21965663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1.
    Guo X; Williams JG; Schug TT; Li X
    J Biol Chem; 2010 Apr; 285(17):13223-32. PubMed ID: 20167603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells.
    Yabut O; Domogauer J; D'Arcangelo G
    J Neurosci; 2010 Mar; 30(11):4004-14. PubMed ID: 20237271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic modifiers of synucleinopathies-lessons from experimental models.
    Lee RMQ; Koh TW
    Oxf Open Neurosci; 2023; 2():kvad001. PubMed ID: 38596238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Synuclein pathology from the body to the brain: so many seeds so close to the central soil.
    Yang Y; Zhang Z
    Neural Regen Res; 2024 Jul; 19(7):1463-1472. PubMed ID: 38051888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.